Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 257

Sort by

Sort Order Select

Journal Articles

Co-mutation of BCOR and BCORL1 was associated with favorable outcome in the adverse risk patients with Acute Myeloid Leukemia

Shunjie Yu, Zongru Li, Lijuan Hu, Ya-Zhen Qin, Guorui Ruan, Yazhe Wang, Hao Jiang, Feifei Tang, Jinsong JIA, Jing Wang, Qiang Fu, Xiaohui Zhang, Lanping Xu, Yu Wang, Yuqian Sun, Yueyun Lai, Hong-Xia Shi, Xiaojun Huang, Qian Jiang

Blood (2025) 146 (Supplement 1): 3400.

https://doi.org/10.1182/blood-2025-3400

Published: 2025

Journal Articles

A novel thiotepa-containing conditioning regimen for haploidentical hematopoietic cell transplantation in pediatric aplastic anemia at high risk of cardiotoxicity

Feng Zhang, Suo Pan, Guanhua Hu, Lu Bai, Yingxi Zuo, Zhengli Xu, Lanping Xu, Yu Wang, Xiaohui Zhang, Xiaojun Huang, Yifei CHENG

Blood (2025) 146 (Supplement 1): 5977.

https://doi.org/10.1182/blood-2025-5977

Published: 2025

Journal Articles

Zanubrutinib combined with bendamustine and rituximab in previously untreated patients with advanced follicular lymphoma: A prospective, open-label, single-arm phase II clinical study

Huang He, Qingqing Cai, Yi Xia, Yirong Jiang, Zhao Wang, Yu Wang, Xiaojie Fang, Lulu Zhang, Jiahao Tian

Blood (2025) 146 (Supplement 1): 5363.

https://doi.org/10.1182/blood-2025-5363

Published: 2025

Journal Articles

Peripheral immune checkpoints predict prognosis and reveal PD-1/treg/IL-10 crosstalk in B cell lymphoma

Bing Pan, Sijia Li, Ruixin Zheng, Kaiyi Liu, Ruyu Ye, Yu Wang, Xiaobo Wang, Li Li

Blood (2025) 146 (Supplement 1): 7088.

https://doi.org/10.1182/blood-2025-7088

Published: 2025

Journal Articles

A novel Janus kinase 1 and 2 inhibitor, baricitinib, for steroid-refractory chronic graft-versus-host disease after allogeneic stem cell transplantation

Chen Zhao, Yuanyuan Zhang, Hai-Xia Fu, Xiao-Dong Mo, Zhi-Dong Wang, Fengrong Wang, Yuhong Chen, Yuqian Sun, Yu Wang, Ying-Jun Chang, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 6015.

https://doi.org/10.1182/blood-2025-6015

Published: 2025

Journal Articles

Combination of mitoxantrone hydrochloride liposome with chidamide in patients with relapsed or refractory peripheral T cell lymphoma: Updated results of the phase II study

Zhiming Li, Peng SUN, Kaiyang Ding, Gang Huang, Hang Yang, Yu Wang

Blood (2025) 146 (Supplement 1): 3639.

https://doi.org/10.1182/blood-2025-3639

Published: 2025

Journal Articles

Clinical characteristics and outcomes of cerebral venous sinus thrombosis in hematologic malignancy patients pre- and post-hematopoietic stem cell transplantation: A single-center retrospective study in China

Juanjuan Li, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Fengrong Wang, Xiang-Yu Zhao, Meng Lv, YuHong Chen, Yu Wang, Ying-jun Chang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3126.

https://doi.org/10.1182/blood-2025-3126

Published: 2025

Journal Articles

Comparable survival with transplant-free approach versus autologous stem cell transplantation in adult relapsed/refractory classic Hodgkin lymphoma achieving complete remission

Panpan LIU, Caiyun Wang, Peng SUN, Hang Yang, Mengqiu Wu, Man Nie, Yu Wang, Qingqing Cai, Yi Xia, Huang He, Huiqiang Huang, Zhiming Li

Blood (2025) 146 (Supplement 1): 5397.

https://doi.org/10.1182/blood-2025-5397

Published: 2025

Journal Articles

IDH1/2 mutations predict a distinct high-risk subset in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia

Lijuan Hu, Sheng-Ye Lu, Lu Yu, Zongru Li, Hao Jiang, Xiaohui Zhang, Lanping Xu, Yu Wang, Qian Jiang, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 3374.

https://doi.org/10.1182/blood-2025-3374

Published: 2025

Journal Articles

Mutational patterns and prognosis in younger versus older AML patients with myelodysplasia-related gene mutations undergoing allogeneic hematopoietic stem cell transplantation

Li-Ping Guo, Yuqian Sun, Meng Lv, Xiao-Dong Mo, Yi-Fei Cheng, Lan-Ping Xu, Xiaohui Zhang, Xiaojun Huang, Yu Wang

Blood (2025) 146 (Supplement 1): 6071.

https://doi.org/10.1182/blood-2025-6071

Published: 2025

Journal Articles

Bzip in-frame mutations might abrogate the adverse prognosis of therapy-related CEBPA-mutated AML

Guanghui Chang, Haitao Gao, Qiang Fu, Xiaosu Zhao, Yu Wang, Qian Jiang, Hao Jiang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Feifei Tang

Blood (2025) 146 (Supplement 1): 5163.

https://doi.org/10.1182/blood-2025-5163

Published: 2025

Journal Articles

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

Ao-Ran Zhang, Guanhua Hu, Xianying Yin, Sheng-Ye Lu, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiangyu Zhao, Xiaojun Huang, Yi-Fei Cheng, Meng Lv

Blood (2025) 146 (Supplement 1): 4298.

https://doi.org/10.1182/blood-2025-4298

Published: 2025

Journal Articles

Transcriptomic analysis identifies lipid metabolism signature of defective erythropoiesis in diamond blackfan anemia syndrome

Kaiwen Deng, Yu Wang, Joseph Min, Xiaofang Liu, Greggory Myers, Lei Yu, Susan Hammoud, Adham Adham, Vaneesha Natogi, Yuanfang Guan, Rami Khoriaty, James Engel, Sharon Singh

Blood (2025) 146 (Supplement 1): 3219.

https://doi.org/10.1182/blood-2025-3219

Published: 2025

Journal Articles

First-line selinexor plus R-CHOP for high-risk GCB-subtype diffuse large B-cell lymphoma: A multi-center, single-arm, Phase II trial

Hang Yang, Peng SUN, Panpan LIU, Yu Wang, Hui Zhou, Ying Lu, Lu Zhang, Keshu Zhou, Zhiming Li

Blood (2025) 146 (Supplement 1): 1922.

https://doi.org/10.1182/blood-2025-1922

Published: 2025

Journal Articles

Low dose of IL-2 application for graft-versus-host disease prophylaxis following haploidentical stem cell transplantation

Xiangyu Zhao, Zhengli Xu, Meng Lv, Xingxing Yu, Yiyang Ding, Ting-ting Han, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Yuqian Sun, Lanping Xu, Xiaohui Zhang, Yu Wang, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 7774.

https://doi.org/10.1182/blood-2025-7774

Published: 2025

Journal Articles

Ectopic EBV infection in T cells following allogeneic hematopoietic stem cell transplantation: Clinical outcomes and immunological characterization

Zhifan Zhao, Lanping Xu, Xiangyu Zhao, Yu Wang, Xiaohui Zhang, Xiaojun Huang, Xuying Pei

Blood (2025) 146 (Supplement 1): 2449.

https://doi.org/10.1182/blood-2025-2449

Published: 2025

Journal Articles

Avatrombopag improves platelet engraftment after haploidentical hematopoietic stem cell transplantation: A randomized, double-blind, multicenter, placebo-controlled trial

Blood (2025) 146 (Supplement 1): 377.

https://doi.org/10.1182/blood-2025-377

Published: 2025

Journal Articles

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Blood (2025) 146 (Supplement 1): 120.

https://doi.org/10.1182/blood-2025-120

Published: 2025

Journal Articles

Single-center retrospective analysis of venetoclax-based triple-drug combination therapy for relapsed Acute Myeloid Leukemia post allogeneic hematopoietic stem cell transplantation.

Xi Yang, cheng Li, Yu Wang, Hong Zheng, Xuemei Ye, Xiaobing Huang

Blood (2025) 146 (Supplement 1): 7808.

https://doi.org/10.1182/blood-2025-7808

Published: 2025

Journal Articles

Development and prospective validation of a prognostic model for diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation

Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Xiaolu Zhu, Yun He, Hai-Xia Fu, Fengrong Wang, Yuanyuan Zhang, Xiao-Dong Mo, Wei Han, Chen-hua Yan, Ting-ting Han, Yao Chen, Yu Wang, Ying-Jun Chang, Xiang-Yu Zhao, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4276.

https://doi.org/10.1182/blood-2025-4276

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Co-mutation of BCOR and BCORL1 was associated with favorable outcome in the adverse risk patients with Acute Myeloid Leukemia

A novel thiotepa-containing conditioning regimen for haploidentical hematopoietic cell transplantation in pediatric aplastic anemia at high risk of cardiotoxicity

Zanubrutinib combined with bendamustine and rituximab in previously untreated patients with advanced follicular lymphoma: A prospective, open-label, single-arm phase II clinical study

Peripheral immune checkpoints predict prognosis and reveal PD-1/treg/IL-10 crosstalk in B cell lymphoma

A novel Janus kinase 1 and 2 inhibitor, baricitinib, for steroid-refractory chronic graft-versus-host disease after allogeneic stem cell transplantation

Combination of mitoxantrone hydrochloride liposome with chidamide in patients with relapsed or refractory peripheral T cell lymphoma: Updated results of the phase II study

Clinical characteristics and outcomes of cerebral venous sinus thrombosis in hematologic malignancy patients pre- and post-hematopoietic stem cell transplantation: A single-center retrospective study in China

Comparable survival with transplant-free approach versus autologous stem cell transplantation in adult relapsed/refractory classic Hodgkin lymphoma achieving complete remission

IDH1/2 mutations predict a distinct high-risk subset in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia

Mutational patterns and prognosis in younger versus older AML patients with myelodysplasia-related gene mutations undergoing allogeneic hematopoietic stem cell transplantation

Bzip in-frame mutations might abrogate the adverse prognosis of therapy-related CEBPA-mutated AML

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

Transcriptomic analysis identifies lipid metabolism signature of defective erythropoiesis in diamond blackfan anemia syndrome

First-line selinexor plus R-CHOP for high-risk GCB-subtype diffuse large B-cell lymphoma: A multi-center, single-arm, Phase II trial

Low dose of IL-2 application for graft-versus-host disease prophylaxis following haploidentical stem cell transplantation

Ectopic EBV infection in T cells following allogeneic hematopoietic stem cell transplantation: Clinical outcomes and immunological characterization

Avatrombopag improves platelet engraftment after haploidentical hematopoietic stem cell transplantation: A randomized, double-blind, multicenter, placebo-controlled trial

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Single-center retrospective analysis of venetoclax-based triple-drug combination therapy for relapsed Acute Myeloid Leukemia post allogeneic hematopoietic stem cell transplantation.

Development and prospective validation of a prognostic model for diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only